FDC
Back to Balance Sheet
|
FDC Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹812 Cr | ₹604 Cr | ₹469 Cr | ₹391 Cr | ₹300 Cr |
What is the latest Total Non-Current Liabilities ratio of FDC ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹812 Cr |
| Mar2024 | ₹604 Cr |
| Mar2023 | ₹469 Cr |
| Mar2022 | ₹391 Cr |
| Mar2021 | ₹300 Cr |
How is Total Non-Current Liabilities of FDC Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹812 Cr | 34.38 | |
| Mar2024 | ₹604 Cr | 28.92 | |
| Mar2023 | ₹469 Cr | 19.81 | |
| Mar2022 | ₹391 Cr | 30.55 | |
| Mar2021 | ₹300 Cr | - | |
Compare Total Non-Current Liabilities of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹6,561.7 Cr | -1.2% | -7% | -16.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | -1.4% | 2.4% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,946.0 Cr | 12.2% | 23.1% | 21.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,907.0 Cr | 2.4% | 5.3% | 41.7% | Stock Analytics | |
| CIPLA | ₹118,674.0 Cr | 1.7% | 0.7% | -3.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,648.7 Cr | 3% | -14.9% | -10.2% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | -1.2% |
-7% |
-16.1% |
| SENSEX | 2.4% |
1.5% |
-4.3% |
You may also like the below Video Courses